Platelet-rich plasma stimulates osteoblastic differentiation in the presence of BMPs

Biochemical and Biophysical Research Communications

Volumn 361, Issue 1, 2007, Pages 62-67

  Tomoyasu, Akihiro ^a   Higashio, Kanji ^a,b   Kanomata, Kazuhiro ^a   Goto, Masaaki ^a,c   Kodaira, Kunihiko ^a,c   Serizawa, Hiroko ^a   Suda, Tatsuo ^a   Nakamura, Atsushi ^a   Nojima, Junya ^a   Fukuda, Toru ^a   Katagiri, Takenobu ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Metabolome Pharmaceuticals Inc   (Japan)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Bone morphogenetic proteins; Osteoblasts; Platelet rich plasma; Scaffolds

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; COLLAGEN; HEPARIN; HYDROXYAPATITE; OSTEOGENIC PROTEIN 1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; IN VITRO STUDY; MOUSE; MYOBLAST; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE RICH PLASMA;

ANIMALS; BLOOD PROTEINS; BONE MORPHOGENETIC PROTEINS; CATTLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHROMATOGRAPHY, AGAROSE; LIGANDS; MICE; MYOBLASTS; OSTEOBLASTS; PLATELET-RICH PLASMA;

EID: 34547126229     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.142     Document Type: Article

References (22)

1. T. Katagiri, T. Suda, K. Miyazono, The bone morphogenetic proteins, in: K. Miyazono, R. Derynck (Eds.), The TGF-β Superfamily Monograph, Cold Spring Harbor, New York, in press.
2. Thomas J.T., Kilpatrick M.W., Lin K., Erlacher L., Lembessis P., Costa T., Tsipouras P., and Luyten F.P. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat. Genet. 17 (1997) 58-64
3. Alden T.D., Varady P., Kallmes D.F., Jane Jr. J.A., and Helm G.A. Bone morphogenetic protein gene therapy. Spine 27 (2002) S87-S93
4. Issack P.S., and DiCesare P.E. Recent advances toward the clinical application of bone morphogenetic proteins in bone and cartilage repair. Am. J. Orthop. 32 (2003) 429-436
5. Kusumoto K., Bessho K., Fujimura K., Akioka J., Okubo Y., Wang Y., Iizuka T., and Ogawa Y. Osteoinduction by recombinant human bone morphogenetic protein-2 in muscles of non-human primates. J. Int. Med. Res. 30 (2002) 251-259
6. Takada T., Katagiri T., Ifuku M., Morimura N., Kobayashi M., Hasegawa K., Ogamo A., and Kamijo R. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J. Biol. Chem. 278 (2003) 43229-43235
7. Zhao B., Katagiri T., Toyoda H., Takada T., Yanai T., Fukuda T., Chung U.I., Koike T., Takaoka K., and Kamijo R. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J. Biol. Chem. 281 (2006) 23246-23253
8. Boyapati L., and Wang H.L. The role of platelet-rich plasma in sinus augmentation: a critical review. Implant Dent. 15 (2006) 160-170
9. Tozum T.F., and Demiralp B. Platelet-rich plasma: a promising innovation in dentistry. J. Can. Dent. Assoc. 69 (2003) 664
10. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., and Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127 (1994) 1755-1766
11. Kodaira K., Imada M., Goto M., Tomoyasu A., Fukuda T., Kamijo R., Suda T., Higashio K., and Katagiri T. Purification and identification of a BMP-like factor from bovine serum. Biochem. Biophys. Res. Commun. 345 (2006) 1224-1231
12. Hattori H., Ishihara M., Fukuda T., Suda T., and Katagiri T. Establishment of a novel method for enriching osteoblast progenitors from adipose tissues using a difference in cell adhesive properties. Biochem. Biophys. Res. Commun. 343 (2006) 1118-1123
13. Kuboki Y., Takita H., Kobayashi D., Tsuruga E., Inoue M., Murata M., Nagai N., Dohi Y., and Ohgushi H. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis. J. Biomed. Mater. Res. 39 (1998) 190-199
14. Toyoda H., Terai H., Sasaoka R., Oda K., and Takaoka K. Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist. Bone 37 (2005) 555-562
15. Kells A.F., Coats S.R., Schwartz H.S., and Hoover R.L. TGF-beta and PDGF act synergistically in affecting the growth of human osteoblast-enriched cultures. Connect. Tissue Res. 31 (1995) 117-124
16. Katagiri T., Lee T., Takeshima H., Suda T., Tanaka H., and Omura S. Transforming growth factor-beta modulates proliferation and differentiation of mouse clonal osteoblastic MC3T3-E1 cells depending on their maturation stages. Bone Miner. 11 (1990) 285-293
17. Abe E. Function of BMPs and BMP antagonists in adult bone. Ann. N. Y. Acad. Sci. 1068 (2006) 41-53
18. Rosen V. BMP and BMP inhibitors in bone. Ann. N. Y. Acad. Sci. 1068 (2006) 19-25
19. Gazzerro E., and Canalis E. Bone morphogenetic proteins and their antagonists. Rev. Endocr. Metab. Disord. 7 (2006) 51-65
20. Lin J., Patel S.R., Cheng X., Cho E.A., Levitan I., Ullenbruch M., Phan S.H., Park J.M., and Dressler G.R. Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease. Nat. Med. 11 (2005) 387-393
21. Yanagita M. Modulator of bone morphogenetic protein activity in the progression of kidney diseases. Kidney Int. 70 (2006) 989-993
22. Urist M.R. Bone: formation by autoinduction. Science 150 (1965) 893-899